The Science of Childhood Cancer is an interactive, weekly lecture series designed to engage the scientific community on key questions in pediatric cancer research. The Fall 2026 lecture season will run August 13-November 19. You may register below for the Fall 2026 season of the series, hosted by the St. Jude Comprehensive Cancer Center

Invited speakers are leading experts across the spectrum of basic, translational, clinical and population science. The Rising Stars of Cancer Research lecture in the 15-week series will feature thematically related talks by two early- to mid-career investigators conducting exciting and innovative work in the field.

Lectures occur each Thursday from 12 pm – 1 pm Central time / 1 pm – 2 pm Eastern time and are often followed by an extended Q&A session. Available recordings will be posted the week following the live event.


Register for the lecture series


Hosts

Event Contacts

Katherine Ford
katherine.ford@stjude.org

Upcoming lectures

August 13, 2026

Developmental Origins of Leukemia Biology

Elvin Wagenblast, PhD
Assistant Professor
Icahn School of Medicine at Mount Sinai


Inhibiting Free Fatty Acid Transport to Improve CAR-T Cell Therapy of Relapsed B-Cell Acute Lymphoblastic Leukemia

Matthew Witkowski, PhD
Assistant Professor
University of Colorado Anschutz Medical Campus

August 20, 2026

New Insights into the Biology, Diagnosis, and Treatment of T-cell Acute Lymphoblastic Leukemia and Lymphoma 

David Teachey, MD
Garrett Brodeur, MD Endowed Chair in Oncology 
The Children’s Hospital of Philadelphia 

August 27, 2026

Metabolic rewiring driving metastasis formation

Sarah-Maria Fendt, PhD
Group Leader
VIB-KU Leuven Center for Cancer Biology

September 3, 2026

Children with childhood cancers and other catastrophic diseases in the Global Public Health Agenda – a call to action.

Bente Mikkelsen, MD, MHA
Director Global Engagement Strategies
St. Jude Children's Research Hospital

September 10, 2026

Ex vivo and In vivo Genome Editing to reprogram T cells 

Justin Eyquem, PhD
Associate Professor
University of California, San Francisco    

September 17, 2026

From Helix Stabilization to Targeted Therapeutics: Stapled Peptides and their PROTAC Chimeras for Wild-Type p53 Cancers 

Loren Walensky, MD, PhD
Attending Physician
Boston Children's Hospital

September 24, 2026

Genetically engineered mouse models of cancer: technology meets biology

Tyler Jacks, PhD
Professor
Massachusetts Institute of Technology

October 1, 2026

Metabolic Heterogeneity in Development and Cancer: Mechanisms and Vulnerabilities

Min Ni, PhD
Assistant Member
St. Jude Children's Research Hospital

October 8, 2026

Charting the inaccessible windows of human development through single-cell atlases and evolutionary transfer learning 

Jay Shendure, MD, PhD
Professor
University of Washington

October 15, 2026

Cure is not the finish line: survivorship science improves lifelong outcomes in pediatrics

Tara Henderson, MD, MPH, FASCO
Chair, Department of Pediatrics
Lurie Children's Hospital

October 22, 2026

Signal transmission from cell surface to target genes: Surprises and implications for therapeutic intervention

Aseem Ansari, PhD
Member, Chair, Department of Chemical Biology and Therapeutics
St. Jude Children's Research Hospital

October 29, 2026

Disease-Defining Molecular Signatures in Childhood Cancer

Adam Schlein, PhD
Senior Scientist
The Hospital for Sick Children

November 5, 2026

Stem Cells in Human AML

Ravi Majeti, MD, PhD
Professor
Stanford University School of Medicine

November 12, 2026

Can Financial Engineering Cure Cancer?

Andrew Lo, PhD
Professor
MIT Sloan School of Management

November 19, 2026

Clonal Adaptation in Bone Marrow Failure: a Mechanism of Protection from Leukemia Development

Marcin Wlodarski, MD, PhD
Member, Director of Bone Marrow Failure and MDS Program
St. Jude Children's Research Hospital

Comprehensive Cancer Center

St. Jude is the first and only National Cancer Institute-designated Comprehensive Cancer Center devoted solely to children